Krystal Biotech (KRYS) Cash from Investing Activities (2016 - 2026)
Krystal Biotech recorded quarterly Cash from Investing Activities of -$63.6 million in Q1 2026, down 669.59% quarter-over-quarter from $11.2 million in Q4 2025, and down 16.09% year-over-year from -$75.8 million in Q1 2025.
Krystal Biotech's Cash from Investing Activities history runs 11 years deep, the most recent figure standing at -$63.6 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 16.09% year-over-year to -$63.6 million; the TTM figure through Mar 2026 stood at -$67.2 million (up 65.03% YoY), while the FY2025 annual figure was -$58.4 million, up 64.26% from the prior year.
- Cash from Investing Activities came in at -$63.6 million for Q1 2026 at Krystal Biotech, down from $11.2 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $105.2 million in Q3 2023 to a low of -$83.8 million in Q4 2024.
- A 5-year average of -$18.6 million and a median of -$16.0 million in 2023 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities tumbled 7384.34% in 2022 and soared 813.5% in 2023, its largest moves.
- Krystal Biotech's Cash from Investing Activities stood at -$5.2 million in 2022, then tumbled by 95.08% to -$10.2 million in 2023, then plunged by 724.59% to -$83.8 million in 2024, then surged by 113.32% to $11.2 million in 2025, then sank by 669.59% to -$63.6 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$63.6 million, $11.2 million, and -$4.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | -63.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.58 Mn |
| Mar 31, 2026 | -63.58 Mn |
| Dec 31, 2025 | 11.16 Mn |
| Dec 31, 2025 | 11.16 Mn |
| Sep 30, 2025 | -4.29 Mn |
| Sep 30, 2025 | -4.29 Mn |
| Jun 30, 2025 | -10.53 Mn |
| Jun 30, 2025 | -10.53 Mn |
| Mar 31, 2025 | -54.77 Mn |
| Mar 31, 2025 | -54.77 Mn |
| Dec 31, 2024 | -83.78 Mn |
| Dec 31, 2024 | -83.78 Mn |
| Sep 30, 2024 | -34.33 Mn |
| Sep 30, 2024 | -34.33 Mn |
| Jun 30, 2024 | -19.35 Mn |
| Jun 30, 2024 | -19.35 Mn |
| Mar 31, 2024 | -25.98 Mn |
| Mar 31, 2024 | -25.98 Mn |
| Dec 31, 2023 | -10.16 Mn |
| Dec 31, 2023 | -10.16 Mn |
| Sep 30, 2023 | 105.19 Mn |
| Sep 30, 2023 | 105.19 Mn |
| Jun 30, 2023 | -15.96 Mn |
| Jun 30, 2023 | -15.96 Mn |
| Mar 31, 2023 | 3.56 Mn |
| Mar 31, 2023 | 3.56 Mn |
| Dec 31, 2022 | -5.21 Mn |
| Dec 31, 2022 | -5.21 Mn |
| Sep 30, 2022 | -14.74 Mn |
| Sep 30, 2022 | -14.74 Mn |
| Jun 30, 2022 | -38.22 Mn |
| Jun 30, 2022 | -38.22 Mn |
| Mar 31, 2022 | -55.91 Mn |
| Mar 31, 2022 | -55.91 Mn |
| Dec 31, 2021 | -126.54 Mn |
| Dec 31, 2021 | -126.54 Mn |
| Sep 30, 2021 | -37.17 Mn |
| Sep 30, 2021 | -37.17 Mn |
| Jun 30, 2021 | -62.32 Mn |
| Jun 30, 2021 | -62.32 Mn |
| Mar 31, 2021 | -747,000.00 |
| Mar 31, 2021 | -747,000.00 |
| Dec 31, 2020 | -6.22 Mn |
| Dec 31, 2020 | -6.22 Mn |
| Sep 30, 2020 | -2.70 Mn |
| Sep 30, 2020 | -2.70 Mn |
| Jun 30, 2020 | -962,000.00 |
| Jun 30, 2020 | -962,000.00 |
| Mar 31, 2020 | -1.31 Mn |
| Mar 31, 2020 | -1.31 Mn |
| Dec 31, 2019 | -591,000.00 |
| Dec 31, 2019 | -591,000.00 |
| Sep 30, 2019 | -682,000.00 |
| Sep 30, 2019 | -682,000.00 |
| Jun 30, 2019 | -1.24 Mn |
| Jun 30, 2019 | -1.24 Mn |
| Mar 31, 2019 | -2.48 Mn |
| Mar 31, 2019 | -2.48 Mn |
| Dec 31, 2018 | -3.77 Mn |
| Dec 31, 2018 | -3.77 Mn |
| Sep 30, 2018 | -2.76 Mn |
| Sep 30, 2018 | -2.76 Mn |
| Dec 31, 2017 | -159,000.00 |
| Dec 31, 2017 | -159,000.00 |
| Sep 30, 2017 | -12,000.00 |
| Sep 30, 2017 | -12,000.00 |
| Jun 30, 2017 | -32,000.00 |
| Jun 30, 2017 | -32,000.00 |
| Mar 31, 2017 | -7,000.00 |
| Mar 31, 2017 | -7,000.00 |
| Dec 31, 2016 | -9,000.00 |
| Dec 31, 2016 | -9,000.00 |